Cleared Special

K001310 - VITROS CHEMISTRY PRODUCTS CREA SLIDE

K001310 is the FDA 510(k) clearance for VITROS CHEMISTRY PRODUCTS CREA SLIDE by Ortho-Clinical Diagnostics, Inc.. It is a Class 2 Chemistry device (product code JFY) cleared through the Special 510(k) pathway after a 10-day FDA review.

K001310 · Ortho-Clinical Diagnostics, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2000
Decision
10d
Days
Class 2
Risk

K001310 is an FDA 510(k) clearance for the VITROS CHEMISTRY PRODUCTS CREA SLIDE, VIRTROS CHEMISTRY PRODUCTS CALIBRATOR .... Classified as Enzymatic Method, Creatinine (product code JFY), Class II - Special Controls.

Submitted by Ortho-Clinical Diagnostics, Inc. (Rochester, US). The FDA issued a Cleared decision on May 5, 2000 after a review of 10 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1225 - the FDA in vitro diagnostics and chemistry framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Ortho-Clinical Diagnostics, Inc. devices

Submission Details

510(k) Number K001310 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 25, 2000
Decision Date May 05, 2000
Days to Decision 10 days
Submission Type Special
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
78d faster than avg
Panel avg: 88d · This submission: 10d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code JFY Enzymatic Method, Creatinine
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1225
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - JFY Enzymatic Method, Creatinine

All 30
Devices cleared under the same product code (JFY) and FDA review panel - the closest regulatory comparables to K001310.
COBAS INTEGRA CREATININE PLUS VER.2 ASSAY
K024098 · Roche Diagnostics Corp. · Dec 2002
CLINITEK ATLAS PRO 12 REAGENT PAK SYSTEM
K021428 · Bayer Corp. · Jul 2002
CREATININE PLUS
K003261 · Roche Diagnostics Corp. · Nov 2000
ABBOTT QUICK START CREATINE KINASE(CK) ITEM #5A17
K912807 · Em Diagnostic Systems, Inc. · Oct 1991
REFLOTRON CREATININE TEST TABS
K913105 · Boehringer Mannheim Corp. · Aug 1991
REFLOTRON CREATININE TEST TABS
K903573 · Boehringer Mannheim Corp. · Sep 1990